Towards Healthcare
Middle East and Africa Life Science Market to Rise at 11.32% CAGR till 2034

Middle East and Africa Life Science Market Industry Shift

Projections indicate that, Middle East and Africa life science industry is projected to rise from USD 4.47 billion in 2024 to USD 13.07 billion by 2034, reflecting a CAGR of 11.32% over the next decade. The market is expanding due to rising R&D investments, technological advancements, and growing demand for precision medicine. In the Middle East and Africa, growth is led by strong government healthcare investments, expanding biopharma manufacturing, and GCC dominance as an innovation hub.

  • Insight Code: 6288
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

FAQ's

The Middle East and Africa life science market holds a valuation of USD 5.04 billion as of 2025, and will expand to USD 13.07 billion by 2034, achieving a CAGR of 11.32% between 2024 and 2034.

GCC countries are currently leading the Middle East and Africa Life Science market due to a focus on healthcare modernization, digital health adoption, and strategic public-private partnerships boosted sector growth.

PerkinElmer (Revvity), Lonza Group, Sartorius AG, Charles River Laboratories, Eurofins Scientific 

Key trends include the growth due to rising R&D investments, technological advancements, and growing demand for precision medicine.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.